Proactiveinvestors USA & Canada Biocept Inc https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Biocept Inc RSS feed en Fri, 18 Sep 2020 23:11:39 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Biocept says it has received more than 35,000 COVID-19 specimens for processing at its San Diego lab https://ca.proactiveinvestors.com/companies/news/929237/biocept-says-it-has-received-more-than-35000-covid-19-specimens-for-processing-at-its-san-diego-lab-929237.html Wed, 16 Sep 2020 13:07:00 -0400 https://ca.proactiveinvestors.com/companies/news/929237/biocept-says-it-has-received-more-than-35000-covid-19-specimens-for-processing-at-its-san-diego-lab-929237.html Biocept inks deal to make its Target Selector cancer assays in-network for 3M US military members, their families https://ca.proactiveinvestors.com/companies/news/928555/biocept-inks-deal-to-make-its-target-selector-cancer-assays-in-network-for-3m-us-military-members-their-families-928555.html Tue, 08 Sep 2020 13:42:00 -0400 https://ca.proactiveinvestors.com/companies/news/928555/biocept-inks-deal-to-make-its-target-selector-cancer-assays-in-network-for-3m-us-military-members-their-families-928555.html Biocept's newly split adjusted stock to begin trading on Nasdaq on September 8 https://ca.proactiveinvestors.com/companies/news/928423/biocept-s-newly-split-adjusted-stock-to-begin-trading-on-nasdaq-on-september-8-928423.html Mon, 07 Sep 2020 12:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/928423/biocept-s-newly-split-adjusted-stock-to-begin-trading-on-nasdaq-on-september-8-928423.html Biocept says it has processed more than 20,000 COVID-19 specimens at its San Diego lab https://ca.proactiveinvestors.com/companies/news/927898/biocept-says-it-has-processed-more-than-20000-covid-19-specimens-at-its-san-diego-lab-927898.html Mon, 31 Aug 2020 16:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/927898/biocept-says-it-has-processed-more-than-20000-covid-19-specimens-at-its-san-diego-lab-927898.html Biocept - Proactive's One2One Virtual Investor Forum https://ca.proactiveinvestors.com/companies/news/927633/biocept---proactive-s-one2one-virtual-investor-forum-927633.html ]]> Wed, 26 Aug 2020 20:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/927633/biocept---proactive-s-one2one-virtual-investor-forum-927633.html Biocept to present at Proactive's One2One Virtual Event https://ca.proactiveinvestors.com/companies/news/927400/biocept-to-present-at-proactive-s-one2one-virtual-event-927400.html Mon, 24 Aug 2020 16:19:00 -0400 https://ca.proactiveinvestors.com/companies/news/927400/biocept-to-present-at-proactive-s-one2one-virtual-event-927400.html Emerging companies to connect with investors via Proactive One2One Investor Forum on August 25 https://ca.proactiveinvestors.com/companies/news/927213/emerging-companies-to-connect-with-investors-via-proactive-one2one-investor-forum-on-august-25-927213.html Mon, 24 Aug 2020 14:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/927213/emerging-companies-to-connect-with-investors-via-proactive-one2one-investor-forum-on-august-25-927213.html Biocept appoints Dr Michael Dugan as chief medical officer and medical director https://ca.proactiveinvestors.com/companies/news/927380/biocept-appoints-dr-michael-dugan-as-chief-medical-officer-and-medical-director-927380.html Mon, 24 Aug 2020 13:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/927380/biocept-appoints-dr-michael-dugan-as-chief-medical-officer-and-medical-director-927380.html Biocept expands availability of its COVID-19 testing services via large healthcare network https://ca.proactiveinvestors.com/companies/news/927054/biocept-expands-availability-of-its-covid-19-testing-services-via-large-healthcare-network-927054.html Wed, 19 Aug 2020 13:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/927054/biocept-expands-availability-of-its-covid-19-testing-services-via-large-healthcare-network-927054.html Biocept awarded US patent to protect its Primer-Switch technology for the detection of rare cell mutations https://ca.proactiveinvestors.com/companies/news/926944/biocept-awarded-us-patent-to-protect-its-primer-switch-technology-for-the-detection-of-rare-cell-mutations-926944.html Tue, 18 Aug 2020 13:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/926944/biocept-awarded-us-patent-to-protect-its-primer-switch-technology-for-the-detection-of-rare-cell-mutations-926944.html Biocept updates on Aegea partnership, 2Q earnings, and coronavirus test deployment https://ca.proactiveinvestors.com/companies/news/926858/biocept-updates-on-aegea-partnership-2q-earnings-and-coronavirus-test-deployment-926858.html Mon, 17 Aug 2020 15:44:00 -0400 https://ca.proactiveinvestors.com/companies/news/926858/biocept-updates-on-aegea-partnership-2q-earnings-and-coronavirus-test-deployment-926858.html Biocept to provide coronavirus testing to mutli-state healthcare group https://ca.proactiveinvestors.com/companies/news/926622/biocept-to-provide-coronavirus-testing-to-mutli-state-healthcare-group-926622.html Thu, 13 Aug 2020 13:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/926622/biocept-to-provide-coronavirus-testing-to-mutli-state-healthcare-group-926622.html Biocept takes on coronavirus testing, trims losses in 2Q results https://ca.proactiveinvestors.com/companies/news/926538/biocept-takes-on-coronavirus-testing-trims-losses-in-2q-results-926538.html Wed, 12 Aug 2020 21:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/926538/biocept-takes-on-coronavirus-testing-trims-losses-in-2q-results-926538.html Biocept strikes agreement with Aegea Biotechnologies to co-develop ultra-sensitive coronavirus detection test https://ca.proactiveinvestors.com/companies/news/926047/biocept-strikes-agreement-with-aegea-biotechnologies-to-co-develop-ultra-sensitive-coronavirus-detection-test-926047.html Thu, 06 Aug 2020 13:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/926047/biocept-strikes-agreement-with-aegea-biotechnologies-to-co-develop-ultra-sensitive-coronavirus-detection-test-926047.html Biocept says lab has processed 6,500 COVID-19 specimens as demand rises for its specimen collection kits https://ca.proactiveinvestors.com/companies/news/925709/biocept-says-lab-has-processed-6500-covid-19-specimens-as-demand-rises-for-its-specimen-collection-kits-925709.html Mon, 03 Aug 2020 12:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/925709/biocept-says-lab-has-processed-6500-covid-19-specimens-as-demand-rises-for-its-specimen-collection-kits-925709.html Biocept proposed reverse stock split endorsed by corporate advisory firms https://ca.proactiveinvestors.com/companies/news/924404/biocept-proposed-reverse-stock-split-endorsed-by-corporate-advisory-firms-924404.html Thu, 16 Jul 2020 14:56:00 -0400 https://ca.proactiveinvestors.com/companies/news/924404/biocept-proposed-reverse-stock-split-endorsed-by-corporate-advisory-firms-924404.html Biocept wins patent in Canada to further protect Target Selector liquid biopsy test technology https://ca.proactiveinvestors.com/companies/news/923114/biocept-wins-patent-in-canada-to-further-protect-target-selector-liquid-biopsy-test-technology-923114.html Tue, 30 Jun 2020 14:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/923114/biocept-wins-patent-in-canada-to-further-protect-target-selector-liquid-biopsy-test-technology-923114.html Biocept to provide coronavirus test kits, will cover out-of-network patients for liquid biopsy tests https://ca.proactiveinvestors.com/companies/news/922984/biocept-to-provide-coronavirus-test-kits-will-cover-out-of-network-patients-for-liquid-biopsy-tests-922984.html Mon, 29 Jun 2020 13:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/922984/biocept-to-provide-coronavirus-test-kits-will-cover-out-of-network-patients-for-liquid-biopsy-tests-922984.html Biocept reaches deal to cover out-of-network patients for its liquid biopsy tests https://ca.proactiveinvestors.com/companies/news/922674/biocept-reaches-deal-to-cover-out-of-network-patients-for-its-liquid-biopsy-tests-922674.html Wed, 24 Jun 2020 14:14:00 -0400 https://ca.proactiveinvestors.com/companies/news/922674/biocept-reaches-deal-to-cover-out-of-network-patients-for-its-liquid-biopsy-tests-922674.html Biocept makes available 10,000 nasopharyngeal specimen collection kits used in coronavirus testing https://ca.proactiveinvestors.com/companies/news/922470/biocept-makes-available-10000-nasopharyngeal-specimen-collection-kits-used-in-coronavirus-testing-922470.html Mon, 22 Jun 2020 15:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/922470/biocept-makes-available-10000-nasopharyngeal-specimen-collection-kits-used-in-coronavirus-testing-922470.html Biocept to relocate corporate offices and lab to new San Diego location https://ca.proactiveinvestors.com/companies/news/921277/biocept-to-relocate-corporate-offices-and-lab-to-new-san-diego-location-921277.html Fri, 05 Jun 2020 13:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/921277/biocept-to-relocate-corporate-offices-and-lab-to-new-san-diego-location-921277.html Biocept's cancer mutation-detecting Target Selector platform affirmed at oncology conference https://ca.proactiveinvestors.com/companies/news/920746/biocept-s-cancer-mutation-detecting-target-selector-platform-affirmed-at-oncology-conference-920746.html Fri, 29 May 2020 14:15:00 -0400 https://ca.proactiveinvestors.com/companies/news/920746/biocept-s-cancer-mutation-detecting-target-selector-platform-affirmed-at-oncology-conference-920746.html Biocept reveals double-digit revenue jump and new Target Selector molecular assay kit https://ca.proactiveinvestors.com/companies/news/920410/biocept-reveals-double-digit-revenue-jump-and-new-target-selector-molecular-assay-kit-920410.html Tue, 26 May 2020 12:44:00 -0400 https://ca.proactiveinvestors.com/companies/news/920410/biocept-reveals-double-digit-revenue-jump-and-new-target-selector-molecular-assay-kit-920410.html Biocept expands molecular assay offering with release of Target Selector BRAF kit https://ca.proactiveinvestors.com/companies/news/919599/biocept-expands-molecular-assay-offering-with-release-of-target-selector-braf-kit-919599.html Thu, 14 May 2020 12:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/919599/biocept-expands-molecular-assay-offering-with-release-of-target-selector-braf-kit-919599.html Biocept 1Q revenue jumps by double-digits while closing with $21.5M in cash https://ca.proactiveinvestors.com/companies/news/919520/biocept-1q-revenue-jumps-by-double-digits-while-closing-with-215m-in-cash-919520.html Wed, 13 May 2020 20:51:00 -0400 https://ca.proactiveinvestors.com/companies/news/919520/biocept-1q-revenue-jumps-by-double-digits-while-closing-with-215m-in-cash-919520.html Biocept receives CE-IVD Mark for Target Selector test kit allowing sales in E.U. https://ca.proactiveinvestors.com/companies/news/918897/biocept-receives-ce-ivd-mark-for-target-selector-test-kit-allowing-sales-in-eu-918897.html Tue, 05 May 2020 19:38:00 -0400 https://ca.proactiveinvestors.com/companies/news/918897/biocept-receives-ce-ivd-mark-for-target-selector-test-kit-allowing-sales-in-eu-918897.html Biocept's mutation-detecting Target Selector kits get nod from EU regulators https://ca.proactiveinvestors.com/companies/news/918322/biocept-s-mutation-detecting-target-selector-kits-get-nod-from-eu-regulators-918322.html Tue, 28 Apr 2020 13:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/918322/biocept-s-mutation-detecting-target-selector-kits-get-nod-from-eu-regulators-918322.html Biocept expands uses for its Target Selector liquid biopsy tech, expands coronavirus testing https://ca.proactiveinvestors.com/companies/news/917973/biocept-expands-uses-for-its-target-selector-liquid-biopsy-tech-expands-coronavirus-testing-917973.html Thu, 23 Apr 2020 13:06:00 -0400 https://ca.proactiveinvestors.com/companies/news/917973/biocept-expands-uses-for-its-target-selector-liquid-biopsy-tech-expands-coronavirus-testing-917973.html Biocept is changing the way physicians examine blood work for their cancer patients https://ca.proactiveinvestors.com/companies/news/224081/biocept-is-changing-the-way-physicians-examine-blood-work-for-their-cancer-patients-224081.html Wed, 22 Apr 2020 11:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/224081/biocept-is-changing-the-way-physicians-examine-blood-work-for-their-cancer-patients-224081.html Biocept expanding uses for its Target Selector liquid biopsy technology to detect cancer biomarkers https://ca.proactiveinvestors.com/companies/news/917648/biocept-expanding-uses-for-its-target-selector-liquid-biopsy-technology-to-detect-cancer-biomarkers-917648.html Mon, 20 Apr 2020 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/917648/biocept-expanding-uses-for-its-target-selector-liquid-biopsy-technology-to-detect-cancer-biomarkers-917648.html Biocept raises around $10.3 million through a further registered direct share offering with several institutional investors https://ca.proactiveinvestors.com/companies/news/917209/biocept-raisesaround-103-million-through-a-further-registered-direct-share-offering-with-several-institutional-investors-917209.html Tue, 14 Apr 2020 14:23:00 -0400 https://ca.proactiveinvestors.com/companies/news/917209/biocept-raisesaround-103-million-through-a-further-registered-direct-share-offering-with-several-institutional-investors-917209.html Biocept to begin coronavirus testing in its highly advanced and certified lab in San Diego https://ca.proactiveinvestors.com/companies/news/917091/biocept-to-begin-coronavirus-testing-in-its-highly-advanced-and-certified-lab-in-san-diego-917091.html Mon, 13 Apr 2020 11:43:00 -0400 https://ca.proactiveinvestors.com/companies/news/917091/biocept-to-begin-coronavirus-testing-in-its-highly-advanced-and-certified-lab-in-san-diego-917091.html Biocept's Target Selector oncogene mutation detection platform wins a patent from Brazil https://ca.proactiveinvestors.com/companies/news/917060/biocept-s-target-selector-oncogene-mutation-detection-platform-wins-a-patent-from-brazil-917060.html Thu, 09 Apr 2020 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/917060/biocept-s-target-selector-oncogene-mutation-detection-platform-wins-a-patent-from-brazil-917060.html Biocept wins patent in Australia for its Primer-Switch technology https://ca.proactiveinvestors.com/companies/news/916497/biocept-wins-patent-in-australia-for-its-primer-switch-technology-916497.html Thu, 02 Apr 2020 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/916497/biocept-wins-patent-in-australia-for-its-primer-switch-technology-916497.html Biocept reveals second contract for assay services after posting sixth consecutive growth quarter https://ca.proactiveinvestors.com/companies/news/916020/biocept-reveals-second-contract-for-assay-services-after-posting-sixth-consecutive-growth-quarter-916020.html Fri, 27 Mar 2020 16:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/916020/biocept-reveals-second-contract-for-assay-services-after-posting-sixth-consecutive-growth-quarter-916020.html Biocept unveils second contract for its assay services with California independent physician association https://ca.proactiveinvestors.com/companies/news/915893/biocept-unveils-second-contract-for-its-assay-services-with-california-independent-physician-association-915893.html Thu, 26 Mar 2020 13:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/915893/biocept-unveils-second-contract-for-its-assay-services-with-california-independent-physician-association-915893.html Biocept posts sixth consecutive growth quarter thanks to increase in commercial test volume https://ca.proactiveinvestors.com/companies/news/915808/biocept-posts-sixth-consecutive-growth-quarter-thanks-to-increase-in-commercial-test-volume-915808.html Wed, 25 Mar 2020 20:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/915808/biocept-posts-sixth-consecutive-growth-quarter-thanks-to-increase-in-commercial-test-volume-915808.html Biocept says published clinical data further validates Target Selector to identify cancer-related mutations https://ca.proactiveinvestors.com/companies/news/914584/biocept-says-published-clinical-data-further-validates-target-selector-to-identify-cancer-related-mutations-914584.html Mon, 09 Mar 2020 14:54:00 -0400 https://ca.proactiveinvestors.com/companies/news/914584/biocept-says-published-clinical-data-further-validates-target-selector-to-identify-cancer-related-mutations-914584.html Biocept prices $6.6M registered direct offering priced at-the-market https://ca.proactiveinvestors.com/companies/news/914405/biocept-prices-66m-registered-direct-offering-priced-at-the-market-914405.html Thu, 05 Mar 2020 14:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/914405/biocept-prices-66m-registered-direct-offering-priced-at-the-market-914405.html Biocept arranges $9.2M financing plan https://ca.proactiveinvestors.com/companies/news/914078/biocept-arranges-92m-financing-plan-914078.html Mon, 02 Mar 2020 15:11:00 -0500 https://ca.proactiveinvestors.com/companies/news/914078/biocept-arranges-92m-financing-plan-914078.html Biocept promotes Cory Dunn to senior vice president of commercial operations https://ca.proactiveinvestors.com/companies/news/912984/biocept-promotes-cory-dunn-to-senior-vice-president-of-commercial-operations-912984.html Fri, 14 Feb 2020 13:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/912984/biocept-promotes-cory-dunn-to-senior-vice-president-of-commercial-operations-912984.html Biocept pursuing new strategy with a physician association using its liquid biopsy cancer tests https://ca.proactiveinvestors.com/companies/news/912687/biocept-pursuing-new-strategy-with-a-physician-association-using-its-liquid-biopsy-cancer-tests-912687.html Tue, 11 Feb 2020 15:42:00 -0500 https://ca.proactiveinvestors.com/companies/news/912687/biocept-pursuing-new-strategy-with-a-physician-association-using-its-liquid-biopsy-cancer-tests-912687.html Biocept partners with California physician association to provide cancer testing https://ca.proactiveinvestors.com/companies/news/912543/biocept-partners-with-california-physician-association-to-provide-cancer-testing-912543.html Mon, 10 Feb 2020 14:57:00 -0500 https://ca.proactiveinvestors.com/companies/news/912543/biocept-partners-with-california-physician-association-to-provide-cancer-testing-912543.html Biocept 'one of the first' liquid biopsy providers to detect cancer biomarkers in fluid around brain https://ca.proactiveinvestors.com/companies/news/911171/biocept--one-of-the-first--liquid-biopsy-providers-to-detect-cancer-biomarkers-in-fluid-around-brain-911171.html Tue, 21 Jan 2020 15:20:00 -0500 https://ca.proactiveinvestors.com/companies/news/911171/biocept--one-of-the-first--liquid-biopsy-providers-to-detect-cancer-biomarkers-in-fluid-around-brain-911171.html Biocept's liquid biopsy tests now available to detect cancer biomarkers in cerebrospinal fluid; shares spike https://ca.proactiveinvestors.com/companies/news/910606/biocept-s-liquid-biopsy-tests-now-available-to-detect-cancer-biomarkers-in-cerebrospinal-fluid-shares-spike-910606.html Tue, 14 Jan 2020 14:52:00 -0500 https://ca.proactiveinvestors.com/companies/news/910606/biocept-s-liquid-biopsy-tests-now-available-to-detect-cancer-biomarkers-in-cerebrospinal-fluid-shares-spike-910606.html Biocept wins US Patent for its liquid biopsy cancer testing technology; shares jump https://ca.proactiveinvestors.com/companies/news/910206/biocept-wins-us-patent-for-its-liquid-biopsy-cancer-testing-technology-shares-jump-910206.html Wed, 08 Jan 2020 15:34:00 -0500 https://ca.proactiveinvestors.com/companies/news/910206/biocept-wins-us-patent-for-its-liquid-biopsy-cancer-testing-technology-shares-jump-910206.html Biocept to showcase data supporting its CTC liquid biopsy testing platform at 2019 San Antonio Breast Cancer Symposium https://ca.proactiveinvestors.com/companies/news/908360/biocept-to-showcase-data-supporting-its-ctc-liquid-biopsy-testing-platform-at-2019-san-antonio-breast-cancer-symposium-908360.html Tue, 03 Dec 2019 13:59:00 -0500 https://ca.proactiveinvestors.com/companies/news/908360/biocept-to-showcase-data-supporting-its-ctc-liquid-biopsy-testing-platform-at-2019-san-antonio-breast-cancer-symposium-908360.html Biocept unveils latest liquid biopsy test to identify cancer-associated proteins https://ca.proactiveinvestors.com/companies/news/907567/biocept-unveils-latest-liquid-biopsy-test-to-identify-cancer-associated-proteins-907567.html Thu, 21 Nov 2019 14:38:00 -0500 https://ca.proactiveinvestors.com/companies/news/907567/biocept-unveils-latest-liquid-biopsy-test-to-identify-cancer-associated-proteins-907567.html Biocept reports record 3Q revenue of $1.5 million as Target Selector testing ramps up https://ca.proactiveinvestors.com/companies/news/907008/biocept-reports-record-3q-revenue-of-15-million-as-target-selector-testing-ramps-up-907008.html Wed, 13 Nov 2019 21:43:00 -0500 https://ca.proactiveinvestors.com/companies/news/907008/biocept-reports-record-3q-revenue-of-15-million-as-target-selector-testing-ramps-up-907008.html Biocept's CEE-Sure Blood Collection Tubes and Shipping Kits now available in Europe https://ca.proactiveinvestors.com/companies/news/906543/biocept-s-cee-sure-blood-collection-tubes-and-shipping-kits-now-available-in-europe-906543.html Thu, 07 Nov 2019 14:31:00 -0500 https://ca.proactiveinvestors.com/companies/news/906543/biocept-s-cee-sure-blood-collection-tubes-and-shipping-kits-now-available-in-europe-906543.html Biocept's Target Selector test to be featured in a major medical conference https://ca.proactiveinvestors.com/companies/news/906241/biocept-s-target-selector-test-to-be-featured-in-a-major-medical-conference-906241.html Mon, 04 Nov 2019 14:07:00 -0500 https://ca.proactiveinvestors.com/companies/news/906241/biocept-s-target-selector-test-to-be-featured-in-a-major-medical-conference-906241.html Biocept making great strides with its Switch-Blocker technology https://ca.proactiveinvestors.com/companies/news/904489/biocept-making-great-strides-with-its-switch-blocker-technology-904489.html Wed, 09 Oct 2019 13:01:00 -0400 https://ca.proactiveinvestors.com/companies/news/904489/biocept-making-great-strides-with-its-switch-blocker-technology-904489.html NA Proactive news snapshot: Genprex, Allot, Ximen Mining, RYAH Medtech UPDATE ... https://ca.proactiveinvestors.com/companies/news/904301/na-proactive-news-snapshot-genprex-allot-ximen-mining-ryah-medtech-update--904301.html Mon, 07 Oct 2019 21:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/904301/na-proactive-news-snapshot-genprex-allot-ximen-mining-ryah-medtech-update--904301.html Biocept's validation testing of Target Selector for cancer mutations published in peer-review journal https://ca.proactiveinvestors.com/companies/news/904282/biocept-s-validation-testing-of-target-selector-for-cancer-mutations-published-in-peer-review-journal-904282.html Mon, 07 Oct 2019 13:25:00 -0400 https://ca.proactiveinvestors.com/companies/news/904282/biocept-s-validation-testing-of-target-selector-for-cancer-mutations-published-in-peer-review-journal-904282.html NA Proactive news snapshot: Nemaura Medical, Q BioMed, Globex Mining Enterprises, Great Panther Mining UPDATE … https://ca.proactiveinvestors.com/companies/news/904122/na-proactive-news-snapshot-nemaura-medical-q-biomed-globex-mining-enterprises-great-panther-mining-update--904122.html Thu, 03 Oct 2019 20:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/904122/na-proactive-news-snapshot-nemaura-medical-q-biomed-globex-mining-enterprises-great-panther-mining-update--904122.html Biocept wins South Korea patent for its Switch-Block technology used to detect rare cancer mutations https://ca.proactiveinvestors.com/companies/news/904105/biocept-wins-south-korea-patent-for-its-switch-block-technology-used-to-detect-rare-cancer-mutations-904105.html Thu, 03 Oct 2019 13:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/904105/biocept-wins-south-korea-patent-for-its-switch-block-technology-used-to-detect-rare-cancer-mutations-904105.html Biocept making progress using artificial intelligence and automation in its diagnostic lab https://ca.proactiveinvestors.com/companies/news/902522/biocept-making-progress-using-artificial-intelligence-and-automation-in-its-diagnostic-lab-902522.html Wed, 11 Sep 2019 18:30:00 -0400 https://ca.proactiveinvestors.com/companies/news/902522/biocept-making-progress-using-artificial-intelligence-and-automation-in-its-diagnostic-lab-902522.html Biocept to tout its liquid biopsy technology Target Selector at major lung cancer conference in Spain https://ca.proactiveinvestors.com/companies/news/901341/biocept-to-tout-its-liquid-biopsy-technology-target-selector-at-major-lung-cancer-conference-in-spain-901341.html Thu, 22 Aug 2019 14:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/901341/biocept-to-tout-its-liquid-biopsy-technology-target-selector-at-major-lung-cancer-conference-in-spain-901341.html Biocept unveils revenue lift in 2Q earnings, bolsters IP portfolio https://ca.proactiveinvestors.com/companies/news/900790/biocept-unveils-revenue-lift-in-2q-earnings-bolsters-ip-portfolio-900790.html Wed, 14 Aug 2019 18:49:00 -0400 https://ca.proactiveinvestors.com/companies/news/900790/biocept-unveils-revenue-lift-in-2q-earnings-bolsters-ip-portfolio-900790.html Biocept bolsters its intellectual property arsenal with three new patents https://ca.proactiveinvestors.com/companies/news/900646/biocept-bolsters-its-intellectual-property-arsenal-with-three-new-patents-900646.html Tue, 13 Aug 2019 16:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/900646/biocept-bolsters-its-intellectual-property-arsenal-with-three-new-patents-900646.html Biocept shares rise after reporting revenue boost in 2Q https://ca.proactiveinvestors.com/companies/news/900565/biocept-shares-rise-after-reporting-revenue-boost-in-2q-900565.html Mon, 12 Aug 2019 21:10:00 -0400 https://ca.proactiveinvestors.com/companies/news/900565/biocept-shares-rise-after-reporting-revenue-boost-in-2q-900565.html Biocept brings tremendous value to the healthcare system with its AI partnership https://ca.proactiveinvestors.com/companies/news/314160/biocept-brings-tremendous-value-to-the-healthcare-system-with-its-ai-partnership-14160.html Mon, 22 Jul 2019 18:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/314160/biocept-brings-tremendous-value-to-the-healthcare-system-with-its-ai-partnership-14160.html Major US laboratory network to carry Biocept’s flagship liquid biopsy tests https://ca.proactiveinvestors.com/companies/news/224289/major-us-laboratory-network-to-carry-biocepts-flagship-liquid-biopsy-tests-224289.html Mon, 22 Jul 2019 13:50:00 -0400 https://ca.proactiveinvestors.com/companies/news/224289/major-us-laboratory-network-to-carry-biocepts-flagship-liquid-biopsy-tests-224289.html Biocept shares jump after supplier of liquid biopsy tests wins patent in China https://ca.proactiveinvestors.com/companies/news/221068/biocept-shares-jump-after-supplier-of-liquid-biopsy-tests-wins-patent-in-china-221068.html Tue, 28 May 2019 08:02:00 -0400 https://ca.proactiveinvestors.com/companies/news/221068/biocept-shares-jump-after-supplier-of-liquid-biopsy-tests-wins-patent-in-china-221068.html Biocept announces commercial launch of its Target Selector panel to detect lung cancer; stock jumps https://ca.proactiveinvestors.com/companies/news/220614/biocept-announces-commercial-launch-of-its-target-selector-panel-to-detect-lung-cancer-stock-jumps-220614.html Mon, 20 May 2019 14:22:00 -0400 https://ca.proactiveinvestors.com/companies/news/220614/biocept-announces-commercial-launch-of-its-target-selector-panel-to-detect-lung-cancer-stock-jumps-220614.html Biocept rises after reporting 7% sequential 4Q growth in billable test volume https://ca.proactiveinvestors.com/companies/news/217464/biocept-rises-after-reporting-7-sequential-4q-growth-in-billable-test-volume-217464.html Thu, 28 Mar 2019 20:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/217464/biocept-rises-after-reporting-7-sequential-4q-growth-in-billable-test-volume-217464.html Biocept shares pop after biotech moves to market pathology platform to urologists https://ca.proactiveinvestors.com/companies/news/217251/biocept-shares-pop-after-biotech-moves-to-market-pathology-platform-to-urologists-217251.html Tue, 26 Mar 2019 14:44:00 -0400 https://ca.proactiveinvestors.com/companies/news/217251/biocept-shares-pop-after-biotech-moves-to-market-pathology-platform-to-urologists-217251.html Biocept prices $8.2M registered direct offering to institutional investors https://ca.proactiveinvestors.com/companies/news/216584/biocept-prices-82m-registered-direct-offering-to-institutional-investors-216584.html Fri, 15 Mar 2019 20:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/216584/biocept-prices-82m-registered-direct-offering-to-institutional-investors-216584.html Biocept rises after announcing expansion of pathology partnership platform https://ca.proactiveinvestors.com/companies/news/216399/biocept-rises-after-announcing-expansion-of-pathology-partnership-platform-216399.html Wed, 13 Mar 2019 13:55:00 -0400 https://ca.proactiveinvestors.com/companies/news/216399/biocept-rises-after-announcing-expansion-of-pathology-partnership-platform-216399.html Biocept rallies after announcing Dubai company will validate patented liquid biopsy technology https://ca.proactiveinvestors.com/companies/news/214203/biocept-rallies-after-announcing-dubai-company-will-validate-patented-liquid-biopsy-technology-214203.html Thu, 07 Feb 2019 16:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/214203/biocept-rallies-after-announcing-dubai-company-will-validate-patented-liquid-biopsy-technology-214203.html Biocept cites peer-reviewed study highlighting success of liquid biopsy testing in lung cancer patients https://ca.proactiveinvestors.com/companies/news/214017/biocept-cites-peer-reviewed-study-highlighting-success-of-liquid-biopsy-testing-in-lung-cancer-patients-214017.html Tue, 05 Feb 2019 15:36:00 -0500 https://ca.proactiveinvestors.com/companies/news/214017/biocept-cites-peer-reviewed-study-highlighting-success-of-liquid-biopsy-testing-in-lung-cancer-patients-214017.html Biocept rallies on release of kits to broaden use of liquid biopsy technology https://ca.proactiveinvestors.com/companies/news/213434/biocept-rallies-on-release-of-kits-to-broaden-use-of-liquid-biopsy-technology-213434.html Mon, 28 Jan 2019 15:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/213434/biocept-rallies-on-release-of-kits-to-broaden-use-of-liquid-biopsy-technology-213434.html Biocept shares climb after getting Japanese patent for rare cancer detection technology https://ca.proactiveinvestors.com/companies/news/207404/biocept-shares-climb-after-getting-japanese-patent-for-rare-cancer-detection-technology-207404.html Thu, 18 Oct 2018 14:31:00 -0400 https://ca.proactiveinvestors.com/companies/news/207404/biocept-shares-climb-after-getting-japanese-patent-for-rare-cancer-detection-technology-207404.html